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Accidents or surgery often cause internal haemorrhage in liver and arteries which may lead to patient morbidity and 
mortality. The current hemostatic agents used for treatment like collagen, oxidized cellulose, and chitosan suffer from side 
effects which include infection, inflammation and even sepsis. In the present study, we studied the spray dried powder 
(SDP) of the aqueous extract of the leaves of  Chromolaena odorata (L.) R.M.King & H.Rob., commonly known as Siam 
weed or Common floss flower and also Christmas bush, for its hemostatic efficacy in two experimental models of surgery. 
Firstly, the SDP was screened through standard pharmacognostical parameters, and a part of the liver was lacerated in rats 
and femoral artery was transected in rabbits to assess the blood loss in pre-weighed gauze with and without treatment. In the 
liver laceration model, an effective blood loss reduction of 54.30 % was observed with oral administration of SDP 7 days 
prior to surgery. Similarly, application of SDP at the site of artery transection caused 70.36% reduction in blood loss as 
compared to the control rabbit artery. The results suggest that oral delivery and/or application of SDP of C. odorata by 
formulating it in a suitable drug delivery tool could minimize perioperative bleeding in hepatic and arterial tissue and 
improve recovery.  
Keywords: Blood loss, Common floss flower, Christmas bush, Hemostatis, Internal haemorrhage, Liver laceration, Siam 
weed, Wound healing 
Haemorrhage can be categorized as internal or 
external depending on the site of injury. Non 
compressible traumatic injury is one of the leading 
cause of death globally
1
. Hepatic trauma or surgery 
leads to excessive blood loss and haemorrhage due to 
it is diffuse in nature. Massive trauma or acute 
coagulopathy can lead to large blood vessel damage 
where natural blood clotting ability becomes 
insufficient. Currently deployed hemostatic agent to 
manage the excessive blood loss includes fibrinogen 
concentrate, tranexamic acid, synthetic platelets
2
 and 
topical hemostatic agents containing collagen, 
oxidized cellulose, and chitosan. However, use of 
these products have been reported to cause allergies, 
embolism, increase the risk of infectious diseases and 
low pH-induced inflammation. Studies also suggests 
that cellulose haemostatic agents are used in internal 
wounds of liver and spleen but some complication 
like sepsis may occur in few patients
3
. Therefore, a 
search for a rapid hemostatic agent that is non-
antigenic, efficacious, absorbable and having 
ability to staunch bleeding at internal sites is the 
 need of the hour. 
Plants belonging to Asteraceae (Compositae) 
family are known for their wound healing and 
hemostatic activity. The most important genus include 
Achillea, Ageatum, Arctium, Artemisia, Caesulia, 
Centaurea, Chromolaena, Cichorium, Dendranthema, 
Eclipta, Gundelia, Helichrysum, Saussurea, 
Scorzonera, Sonchus, Tagetes, Tanacetum, Tridax and 
Vernonia
4
. The Siam weed or Common floss flower, 
Chromolaena odorata (L.) R. M. King & H. Rob., 
formerly known as Eupatorium odoratum Linn., has 
been studied extensively for its pharmacological and 
therapeutic potential including anti-inflammatory 
activity
5
, membrane stabilizing activity
6
; inhibition of 
hydrated collagen lattice contraction by normal 
human dermal fibroblasts
7
; decreasing the bleeding 







 and erythropoietic activity
12
; 
healing of skin infection
13
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evaluations play a pivotal role
15
. Moreover, 
pharmacognostical tests also help in distinction from 
other allied species and adulterants and guarantee the 
safe use of quality products and combat seasonal 
variations, if any
16
. Microscopy and macroscopy of 
leaves of C. odorata is well documented and 
reported
17
. Hence, emphasis has been given on other 
pharmacognostical parameters in the present study. In 
addition, our previous study revealed the hemostatic 
efficacy of the spray dried powder (SDP) in other 
bleeding models of thrombocytopenia, heavy use of 
anticoagulant and gastric ulcer when administered 
orally
18
. However,  its efficacy in preventing blood 
loss in internal hemorrhagic situation has not been 
studied until now. Thus, in the present work, we have 
made an attempt to lay down the hemostatic  
potential of spray dried powder of C. odorata  
in surgery models of liver laceration and femoral 
artery injury when administered by oral and topical 
route, respectively. 
 
Material and Methods 
 
Collection and Authentication of plant material 
The leaves of Chromolaena odorata (L.) R. M. 
King & H. Rob. was collected from Vadgaon khurd, 
Pune district of Maharashtra and was authenticated by 
Dr. J. Jayanthi from Botanical Survey of India (BSI), 
Pune under the number BSI/WRC/Cert./2014. A 
voucher specimen of the herbarium was submitted in 
APT Research Foundation, Pune for further reference. 
 
Preparation of plant extracts 
The leaves were cleaned and shade dried in a  
shade dryer and the dried leaves obtained were 
powdered. It was then extracted in soxhlet apparatus 
with Millipore RO water. The aqueous extract 
obtained was concentrated in rotary evaporator under 
vacuum and percent yield was determined by using 
the formula: Weight of the Extract/Weight of the 




Preparation of Spray dried powder (SDP) 
The liquid extract obtained was first atomized and 
allowed to contact with hot air which results in 
evaporation to yield dried particles. These particles 
are subsequently separated from the air stream by 
pressure of cyclone mixer inbuilt in spray drying 
machine. Briefly, the blower was started and desired 
inlet temperature of 150ºC and outlet temperature of 
80ºC was set in the panel
20
. The heater was started till 
the desired temperature is achieved followed by 
starting the compressor at 0.70 kg/cm
2
. Later, the feed 
pump was set at 14 RPM to achieve feed rate of about 
750 mL/h. It was ensured not to have particles which 
might block nozzle of the atomizer. The powder 
obtained after spray drying was tightly packed in air 
tight containers for further experiments. 
 
Pharmacognostical screening of SDP 
The SDP of C. odorata was subjected to various 
pharmacognostical screening procedures such as 
phytochemical screening
21
. Further, fluorescent 
characteristics of SDP was done by treating it with 
chemical reagents and were observed in day light as 
well as under UV radiation. Fluorescent analyses of 
all the plant powders were carried out according to the 
standard protocols
22
. Physicochemical evaluation of 
the fine powder was performed following an 
established protocol
23
. The parameters evaluated were 
moisture content, extractive yield, spray dried yield, 
crude fibre content, total ash, water soluble ash, acid 
soluble ash, sulphated ash. Determination of heavy 
metals, such as Arsenic (As), Chromium (Cr), Lead 
(Pb), Mercury (Hg), Cadmium(Cd) and Iron (Fe) in the 
fine powder was performed using atomic absorption 
spectroscopy (AAS) (model no.: AA-6300 Shimadzu) 
according to standard protocols
24
. Calibration of the 
instrument was performed using a blank solution to 
zero. The standard samples were loaded followed by 
the test sample and the absorbance was recorded and 
data expressed as mg/kg. To monitor the microbial 
contamination in the SDP of C. odorata, microbial 
analysis was carried out using 1.0 g of spray dried 
powder in 20 mL of sterile distilled water as stock 
solution. One mL from the above stock solution was 
mixed by vortexing into 9 mL sterile normal saline for 









) was poured on Nutrient Agar (NA) 
plates and Chloramphenicol Yeast Glucose Agar 
(CYGA) plates by pour plate method. The NA plates 
were kept at 37ºC and CYGA plates were kept at  
28-30ºC for incubation for 24 h and 48-72 h, 
respectively
25
. Similarly, 1.0 mL each of the same 
samples was poured on Mac Conkey‟s Agar plate, 
Brilliant Green Agar plate for detection of E. coli, and 
Salmonella-Shigella spp., respectively. At the end of 
the incubation period, the number of colony-forming 
units per gram (CFU/g) was calculated.
 
Accelerated shelf life storage stability study on 
SDP was conducted by keeping the samples at room 
temperature of 37°C on Day „0‟ and at 54°C for 14 
days
26
. Briefly, on the day of analysis, 20 mg of 
powdered sample was weighed into a 100 mL 




volumetric flask and 30 mL of water was added  
and sonicated for about 5 min to dissolve. Finally, 
volume was made up to 100 mL with water. A portion 
of this solution was filtered through Whatman 41 
filter paper and analyzed by HPLC-DAD method in 
Agilent 1260 HPLC with DAD Detector using C18 
(250 mm length × 4.6 mm i.d. × 5 μm particle size. 
The mobile phase used was acetonitrile: water (35:65) 
with flow rate of 1.0 mL /min and run time was  
10 min. Similarly, 18 months‟ shelf life storage 
stability study on spray dried powder was conducted 
by keeping the samples in stability chamber at 
temperature 40±2°C and relative humidity of 75±5% 
for 18 months. Samples were made into aliquots and 













time points by HPLC-DAD method as mentioned 
above. 
 
Spectral fingerprinting of SDP of C. odorata 
The spray dried powder obtained was taken and  
2 mg/2 mL solution was prepared. The sample was 
run in a UV visible spectrophotometer to obtain the 
fingerprinting from 200-900 nm
27
. For the HPLC of 
SDP, a 20 µL from 5% aqueous solution is made up 
to 10 mL by distilled water. The solution was filtered 
through 0.22 µ filter and 4 mL each was distributed in 
two vials and sent for analysis to Venture Centre, 
Pune. HPLC peak were observed using the solvent 
system methanol:water at the ratio 60:40, run time 
1.0mL/minute and detected at 268 nm. Subsequently, 
HPTLC of spray dried powder was conducted by 
macerating 2 g of powdered drug with 10 mL 
methanol (5-7 h). The crude extract was filtered and 
concentrated to dryness and from that, 5 mg of the 
residue was dissolved in 10 mL of methanol. About 
10 µL of the sample was injected to CAMAG 
Linomat 5 “Linomat5-210175” S/N 210175 (1.00.13) 
and sample allowed to run in the Solvent system of  
n-Hexane: Ethyl acetate (6:4). The stationary phase 
used was 5 × 10 cm TLC silica gel 60 F254 (Merck). 
For derivatization, the plate was immersed into 
anisaldehyde sulphuric acid reagent for 1 second then 
heated at 120°C for 5 min
28
. The plates were scanned 
in CAMAG TLC scanner 4 at 254 nm, 366 nm and 
540 nm wavelength. 
Ultimately, particle size analysis of SDP was done 
by preparing a solution with concentration 1.0 mg/mL 
of SDP. From that 400 µL was made upto 12 mL with 
methanol.  About 3 mL sample was analyzed with 
Brookhaven Instrument Corp. and analyzed with 90+ 
particle sizing software Ver 4.12. 
Pharmacological hemostatic efficacy of C.odorata 
 
Animal experimentation for liver laceration model 
All animal study was done as per the approval 
of Institutional Animal Ethics Committee 
conducted by following the principles of 
CPCSEA, GoI. The study was approved by IAEC 
with the protocol no. RP. No. 06/1617 of APT Testing 
and Research Pvt. Ltd. Pune, and conducted by 
following the principles of CPCSEA. Twelve male 
Wistar rats weighing 200-250 g were housed under 
standard conditions of temperature (24±2ºC) and 
relative humidity (40-60%) with 12 h light/dark cycle. 
Animals were fed on standard commercial pellet diet 
and water ad libitum. Rats were divided into two 
groups of Control and Test (n=6). Animals were 
anesthetized 75 mg/kg ketamine hydrochloride  
+10 mg/kg xylazine i.p.
29
. The rats were positioned 
with the tail toward the surgeon. A midline 
laparotomy was performed to expose the abdominal 
cavity, and the left lobe of the liver was exposed.  
A 3.0 × 1.5 cm section of the edge of the left liver 
lobe was transected to cause liver injury
30
. Pre-
weighed gauze was placed inferior to the liver before 
injury. The gauze was replaced and weighed at 
intervals. The process was repeated for 3 min or until 
blood stops flowing from the lacerated area. 
 
Animal experimentation for Femoral Artery Injury model 
One of the objectives of the present study was to 
assess the surgical hemostatic effects of topical 
application of SDP on major arterial vessel injury. The 
study was approved by IAEC with the protocol no. RP. 
No. 06/1617 of APT Testing and Research Pvt. Ltd. 
Pune, and conducted by following the principles of 
CPCSEA. Six New Zealand white rabbits were used 
for the study and housed under standard conditions of 
temperature and relative humidity with 12 h light/dark 
cycle. Animals were fed on standard commercial pellet 
diet and water ad libitum.  SDP coated gauze was 
topically applied to the femoral artery puncture in  
1 extremity in each animal (femoral artery 1), but not 
to the other extremity, which served as the control 
(femoral artery 2). 
All of the rabbits underwent surgery under proper 
general anaesthesia without intubation. Anaesthesia 
was provided via intramuscular injection of ketamine 
hydrochloride 35 mg/kg and xylazine hydrochloride  
5 mg/kg
31
. After administration of anaesthesia, both 
femoral arteries were explored using a sterile surgical 
technique, and separated from the femoral vein and 
femoral nerve. The femoral arteries were rounded 




with tapes and a 21G injector needle was inserted to 
induce major bleeding. When bleeding began, 
compression with control gauzes was immediately 
applied in the right leg and test gauzes were 
immediately applied in the left leg and the bleeding 
time was calculated. The blood loss was monitored by 






Results are expressed as percentages and Mean ± 
SD. For animal Studies, data are analyzed by 
Student‟s T-Test and compared with non-treated 




Pharmacognostical screening of SDP 
Data in Table-1 represent the various phytochemicals 
present in the crude powder, aqueous extract and SDP of 
C. odorata. Followed by this, the fluorescence of SDP of 
C. odorata was monitored in visible and UV light as 
depicted in Table 2. The physicochemical parameters 
were also analysed to detect the presence of inorganic 
and organic material present in the SDP of C. odorata 
which is tabulated in Table 3. Weeds such as C. odorata 
generally uptake heavy metals from the soils which in 
turn may attribute as a contaminant in the process of 
developing a herbal medicine. Therefore, the presence or 
absence of these heavy metals were analyzed in the 
present study and found to be in the permissible limits 
except Cadmium as given in Table 4. In the same way, 
the SDP of C. odorata was assessed for its microbial 
load with special reference to E.coli, Salmonella and 
fungi and was found to have negligible count when 
grown in controlled environment as illustrated in Fig. 1. 
Accelerated shelf life testing of SDP was undertaken to 
do comparative analysis of SDP after storage at 37°C on 
 
 
Fig. 1 — Negligible Microbial count in SDP of Chromolaena odorata indicating absence of microbial contamination 













Flavonoids Alkaline reagent test ++ ++ ++ 
Alkaloids Dragendorff‟s Test + + + 
Carbohydrate Benedicts Test + + + 
Glycosides Keller Killiani Test - - - 
Saponins Foam Test +++ +++ +++ 
Proteins Biuret Test - - - 
Phenols and Tannins Ferric Chloride test + + + 
Phytosterols Salkowski Test - - - 
 
Table 2 — Fluoroscence analysis of SDP of C. odorata 
Tests Visible UV (354 nm) 
Powder+distilled water brown black 
Powder+acetone dark green pink 
Powder+ethanol dark green pinkish red 
Powder+benzene olive green pinkish red 
Powder+chloroform dark green brown 
Powder+methanol dark green green 
Powder+petroleum ether yellow orange 
Powder+glacial acetic acid olive green greenish blue 
Powder+sulphuric acid reddish brown green 
Powder+nitric acid orange brown 
Powder+HCl green green 
Powder+5% FeCl3 yellowish green dark green 
Powder+5% I2 brown gray 
Powder+picric acid greenish yellow greenish black 
Powder+1 N NaOH brownish yellow orange 
Powder+1 N NaOH+methanol yellowish green brown 
Table 3 — Physicochemical analysis of SDP of C. odorata 
Parameters 1st Batch 2nd Batch 3rd Batch 4th Batch 
Moisture Content 75.01% 77.49% 73.92%  74.00%  
Extractive yield 16.00% 28.50%  29.00%  30.00%  
Spray Dried Yield 7.14% 7.01% 7.45%  12.00%  
Crude fibre 0.60% 0.78% 0.79%  0.83%  
Total ash 12.85% 14.58% 13.27%  13.15%  
Water Soluble Ash 4.43% 3.41% 3.80%  4.68%  
Acid Soluble Ash 1.02% 4.72% 3.87%  3.37%  
Sulphated Ash 16.74% 17.12% 17.35%  16.63%  
 











Arsenic 5  <0.2 <0.2 Less than limit 
Chromium 2  <0.5 <0.5 Less than limit 
Lead 10 2.93 1.35 Less than limit 
Mercury 0.2 <0.2 <0.2 Less than limit 
Cadmium 0.3 0.98 0.59 More than limit 
Iron - 1048.4 298.6  




day 0 and at 54°C for 14 days. No significant deviations 
in peak shape were observed. Similarly, no significant 













 month time points by HPLC indicating 
it can be safely stored and used for the stipulated period 
without change in colour, odour and texture of SDP of 
C. odorata. 
 
Spectral fingerprinting of SDP of C.odorata 
The Fig. 2 showed the UV Visible spectra of SDP 
at 200 nm to 900 nm which was similar in every batch 
of collection. In Fig. 3A, the HPLC spectral image 
showed presence of small peaks and an unidentified 
peak at 3.4 retention time at 268 nm. Unlike the 
HPLC data, the HPTLC data showed multiple number 
of bands at 254, 366, after derivatization and at  
560 nm, respectively as seen in Fig. 3B. 
Figure 4 shows that the spray dried sample 
obtained from laboratory spray drier has uniformity in 
size distribution of particles which may suggest that 
the sample is not adulterated with mixed dimension 
particles.  
 
Pharmacological hemostatic efficacy of C. odorata 
Animal experimentation for liver laceration model 
was conducted by pretreatment of rats for 7 days at 
500 mg/kg dose orally. This dose was selected based 
on the 90 days sub-acute oral toxicity study done as 
per OECD guidelines 408. The treatment has showed 
statistically significant reduction in the blood loss in 
dissected liver tissue by 54.30% (P <0.05). Rats were 
humanely sacrificed after 72 hours as there was no 
mortality in test as well as the control groups. The 
amount of blood loss and number of gauges required 




Fig. 2 — The UV visible spectra of the SDP of Chromolaena 




Fig. 3 — (A) HPLC spectral fingerprinting of SDP of C. odorata; 










Fig. 5 — The graphs showing reduction of bleeding diathesis in 
rats treated with SDP of Chromolaena odorata 




Animal experimentation for femoral artery injury 
model was performed in rabbits to monitor the 
duration of the blood flow from transacted artery after 
topical administration of SDP of C. odorata at the site 
of injury. The right limb of 3 rabbits served as control 
and the left limb of those 3 rabbits served as test. To 
avoid blood loss due to ambiguity between right and 
left limb, in the second set of experiment, the left limb 
of 3 rabbits served as control and right limb of those 3 
rabbits served as test. The mean blood flow time in 
minutes was found to be 27±5 min in control whereas 
it was reduced to 8±3 min in test treated group 
indicating statistical significant (P <0.05) hemostatic 
effect of C. odorata. 
 
Discussion 
In a recent review published it is reported that 90% 
of the combat casualties are due to haemorrhage in 
mostly truncal, junctional and extremities of the body
33
. 
In both civilian and military trauma, deaths due to 
haemorrhage occur in the first several hours after 
injury. Therefore, fast acting efficacious hemostatic 
agent is of utmost need to save lives
34
. The latest trend 
is to provide handy and portable hemostatic products 
such as Combat Gauze in emergency medical 
services
35
. It is always desirable that hemostatic agent 
should have high stability at extreme conditions and 
most importantly have the properties of being quick 





Scientific reports suggest that for externally 
accessible injuries, robust research is done and 
biomaterials including glues, bandages, tamponades, 
tourniquets, dressings, and procoagulant powders 
have come up. In contrast, challenge lies with the 
treatment of internal non-compressible haemorrhage 
that depends on transfusion of whole blood or blood's 
hemostatic components like platelets, fibrinogen, and 




In the present study, focus was to develop a 
hemostatic agent that will meet the above criteria and 
can be formulated for two routes of dosing (oral and 
at site of injury). Ample evidence suggests that patch 
products enable delivery of pro-coagulants to defined 
areas and chances of dilution and/or displacement is 
lesser
38
. But before working on the aforementioned 
principles for developing biopharmaceutical 
hemostatic agent, some basic pharmocognostical 
aspects have to be studied. Due to the lack of 
reproducible quality of herbal products, major 
concerns have developed on the value of herbal drugs 





In the present study, phytochemical analysis was 
done for detecting the presence of bioactive components 
followed by fluorescence test which is known to 
exhibit various chemical constituents of the plants that 




For determining the physicochemical parameters, 
extractive values are important parameter as it 
determines adulterated materials and solubility of the 
chemical constituents. Ash value also gives an idea of 
the earthy matter or the inorganic composition and 
other impurities present along with the drug
41
. 
Similarly, presence of increased heavy metal content 
in herbal materials leads to decreasing quality of the 
herbal product, which directly or indirectly becomes 
responsible for causing several adverse effects
42
.  
C. odorata was found to have more iron in leaves and 
all other harmful heavy metals were within the 
permissible limits established by WHO. 
 
Another important parameter in maintaining the 
quality of herbal drug is microbial analysis of the 
extract which indicates that the powdered drug is free 
from specific pathogens such as Escherichia coli, 
Salmonella species, Pseudomonas aeruginosa and 
Staphylococcus aureus including Fungi
43
. In the 
present study, the total microbial load was within the 
permissible limits. Nowadays, spectral analysis is 
gaining importance as a tool for fingerprinting and 
identification of wide range of substances in less 
time
44
. Therefore, C. odorata was collected in four 
seasons and were analyzed by UV Visible spectrum, 
HPLC and HPTLC fingerprinting methods to identify 
the seasonal variations if any. It is important that 
spray dried powder (SDP) of C. odorata remain 
physically stable throughout their shelf life, and for 
that no or a minimal change in the particle size 
distribution is necessary. The mean droplet size was 
found to be around 951 nm with a polydispersity 
index of 0.225 indicating good uniformity amongst 
the samples. The Baseline index (B. I) was seen to be 
98.66% for this trial which is relative to the accuracy 
of the data. 
 
The future perspective of the SDP is to formulate it 
into drug loaded/coated bandages that will help as 
hemostatic agent in perioperative bleeding. Therefore, 




the pharmacognostic and physicochemical characters 
is vital source of information and provided suitable 
standards to determine the quality of the SDP of the 
leaf extract of C. odorata for future investigations. 
 
After standardization of the quality of C. odorata, 
emphasis was given on its role in hemostatc surgery 
model. Uncontrollable haemorrhage is a significant 
concern in veterinary and human surgery which 
occurs as a result of blunt or penetrating trauma and 
leads to increased morbidity and mortality
45
. The liver 
is the most vessel-rich organ and does not have 
smooth muscle and has few collagen tissues for which 
vasoconstriction cannot occur and parenchymal 
stitches do not get benefited by the resistance created 
by collagen fibers
46
. Presently, hemostatic strategies 
for traumatic and surgical bleeding includes: 
biologically derived materials like albumin, collagen, 
gelatin, polypeptides, keratin, chitosan, cellulose, and 
dextran; Synthetically derived materials, such as 
biologically mimetic adhesives, in situ forming 
sealants, direct activators and aggregators, and 
aluminosilicates, and intravenously administered 
hemostatic agents like coagulation factors, anti-





Internal or external wounds can be incision, 
laceration, puncture, abrasion, avulsions or amputation 
in nature. In most types of wounds, the blood vessels 
may rupture which include arteries, veins and capillaries. 
The venous and the capillary rupture does not cause 
much blood loss as compared to arterial rupture 
because oxygenated dark red blood oozes as spurts 
from broken arteries rather than steady flow in veins. 
This fact has motivated us to study a model of blood 
loss in femoral artery damage by placing pre-coated 
gauze with the proposed hemostatic agent SDP. In the 
present study, the SDP effectively controlled blood loss 
in the liver laceration model when SDP was administered 
orally and the reduction percent of the amount the 
blood loss in dissected liver tissue by 54.30%. The 
practical implementation of this oral therapy can be 
used for patients with acute coagulopathies and the 
ones who use blood thinning medications prior to 
pancreatobiliary or pancreaticoduodenectomy or any 
major or minor surgeries. Similarly, in the femoral 
artery damage models SDP was applied at the site of 
injury and it caused 70.36% reduction in blood loss as 
compared to control artery. Another important aspect 
due to which there is an inclination towards herbal 
source of hemostatic agent is because the fibrinogen, 
thrombin and synthetic hemostatic material are costly 
and scarcely available
48
. Therefore, it can be 
hypothesized that the present intervention can be used 
for sports injury as well as traumatic injuries to 
overcome blood loss to some extent. 
 
Conclusion 
Results of this study demonstrated the hemostatic 
efficacy of the spray dried powder (SDP) of the 
aqueous extract of Chromolaena odorata leaves by 
improved hemostasis in both, the surgical model of 
hepatic haemorrhage and the arterial damage. As 
evident from the results, a statistical significant 
reduction in blood loss proves its candidature for 
possible use as hemostatic agent that is non allergic, 
fast acting and with strong adherence to the site of 
injury. From this preliminary study, we can only 
hypothesize that oral delivery and/or application of 
SDP of C. odorata to bleeding hepatic and arterial 
tissue would result in decreased haemorrhage and 
improved post operational recovery/survival. The 
expected outcome from this preliminary study gives us 
motivation to work extensively on its active molecules 
isolation and warrant more elaborate study in future for 
developing biopharmaceuticals from C. odorata. 
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